CVE-2018-14787
3Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackepss 0.4%
exploitation probability
0.4%top 67% of all CVEs
observed exploitation
nono source reports it
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.
Affected products
Philips · IntelliSpace Cardiovascular (ISCV) products